CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,244 | -27.6% | 112,975 | +12.6% | 0.05% | -29.2% |
| Q4 2022 | $4,598,220 | -20.9% | 100,354 | -16.4% | 0.07% | -10.0% |
| Q3 2022 | $5,816,000 | +64.5% | 120,000 | +33.3% | 0.08% | +63.3% |
| Q2 2022 | $3,536,000 | +60.1% | 90,000 | +50.0% | 0.05% | +88.5% |
| Q1 2022 | $2,208,000 | -19.2% | 60,000 | 0.0% | 0.03% | -13.3% |
| Q4 2021 | $2,734,000 | -47.2% | 60,000 | -58.6% | 0.03% | -49.2% |
| Q3 2021 | $5,182,000 | +468.8% | 145,000 | +215.2% | 0.06% | +391.7% |
| Q2 2021 | $911,000 | +35.0% | 46,000 | +41.5% | 0.01% | -20.0% |
| Q4 2020 | $675,000 | -96.2% | 32,500 | -96.0% | 0.02% | -96.4% |
| Q3 2020 | $17,568,000 | +1040.8% | 811,500 | +1142.7% | 0.41% | +705.9% |
| Q2 2020 | $1,540,000 | +213.0% | 65,300 | +56.5% | 0.05% | +82.1% |
| Q1 2020 | $492,000 | +200.0% | 41,736 | +189.8% | 0.03% | +211.1% |
| Q3 2019 | $164,000 | -51.3% | 14,400 | -52.0% | 0.01% | -47.1% |
| Q2 2019 | $337,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |